This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (65)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Progress and Prospects

James I. Cleeman, MD; Claude Lenfant, MD

JAMA. 1998;280:2099-2104.

The National Cholesterol Education Program (NCEP) is a prime example of the role the National Heart, Lung, and Blood Institute has played, in its 50 years of existence, as a catalyst for translating research advances into improved clinical and public health practices. Since its inception in 1985, the NCEP has adhered to 2 principles in mounting educational campaigns for professionals and the public: building on a strong science base and working in partnership with other organizations. In slightly more than a decade, the NCEP has made significant progress toward its goal of reducing the prevalence of high blood cholesterol. The impact of cholesterol education is clearly visible in 4 major trends: increasing professional and public cholesterol awareness; declining dietary intakes of saturated fat, total fat, and cholesterol; falling serum cholesterol levels; and a continuing decline in coronary heart disease (CHD) mortality rates. Nevertheless, cholesterol levels are still being undertreated, especially in patients with CHD, and substantial scientific and educational challenges remain. As it looks forward to the 21st century, the NCEP plans to make continued progress by using emerging scientific developments and pursuing the powerful combination of cholesterol lowering in CHD patients and in primary prevention.

From the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, Bethesda, Md.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

A Quarter Century of Health Maintenance
Mike Mitka
JAMA. 1998;280(24):2059-2060.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Associations Between Serum Lipids and Causes of Mortality in a Cohort of 3499 Urban Thais: The Electricity Generating Authority of Thailand (EGAT) Study
Sritara et al.
ANGIOLOGY 2008;58:757-763.
ABSTRACT  

Patients' Perceptions of Cholesterol, Cardiovascular Disease Risk, and Risk Communication Strategies
Goldman et al.
Ann Fam Med 2006;4:205-212.
ABSTRACT | FULL TEXT  

Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part IV: The 1984 Coronary Primary Prevention Trial ends it--almost
Steinberg
J. Lipid Res. 2006;47:1-14.
ABSTRACT | FULL TEXT  

The Relative Impact of Inadequate Primary and Secondary Prevention on Cardiovascular Mortality in the United States
Qureshi et al.
Stroke 2004;35:2346-2350.
ABSTRACT | FULL TEXT  

Thirty-year Trends in Cardiovascular Risk Factor Levels among US Adults with Diabetes: National Health and Nutrition Examination Surveys, 1971-2000
Imperatore et al.
Am J Epidemiol 2004;160:531-539.
ABSTRACT | FULL TEXT  

Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies
Yarnell et al.
Eur Heart J 2004;25:1049-1056.
ABSTRACT | FULL TEXT  

Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology
Pappolla et al.
Neurology 2003;61:199-205.
ABSTRACT | FULL TEXT  

Contemporary Awareness and Understanding of Cholesterol as a Risk Factor: Results of an American Heart Association National Survey
Nash et al.
Arch Intern Med 2003;163:1597-1600.
ABSTRACT | FULL TEXT  

The Need to Improve
Bergstrom
Diabetes Care 2003;26:1633-1634.
FULL TEXT  

References
Circulation 2002;106:3373-3421.
FULL TEXT  

Use of Cholesterol-Lowering Therapy by Elderly Adults After Myocardial Infarction
Ayanian et al.
Arch Intern Med 2002;162:1013-1019.
ABSTRACT | FULL TEXT  

Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma
Sun et al.
Am. J. Clin. Nutr. 2001;74:308-314.
ABSTRACT | FULL TEXT  

Ineffective Secondary Prevention in Survivors of Cardiovascular Events in the US Population: Report From the Third National Health and Nutrition Examination Survey
Qureshi et al.
Arch Intern Med 2001;161:1621-1628.
ABSTRACT | FULL TEXT  

Cholesterol reduction: What can we afford?
Luepker
Eur Heart J 2001;22:720-721.
 

Choose a Diet That Is Low in Saturated Fat and Cholesterol and Moderate in Total Fat: Subtle Changes to a Familiar Message
Dixon and Ernst
J. Nutr. 2001;131:510S-526.
ABSTRACT | FULL TEXT  

Trends and Disparities in Coronary Heart Disease, Stroke, and Other Cardiovascular Diseases in the United States : Findings of the National Conference on Cardiovascular Disease Prevention
Cooper et al.
Circulation 2000;102:3137-3147.
ABSTRACT | FULL TEXT  

Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: effects of energy intake
Kasim-Karakas et al.
Am. J. Clin. Nutr. 2000;71:1439-1447.
ABSTRACT | FULL TEXT  

Barriers to Control of Blood Glucose in Diabetes Mellitus
Dalewitz et al.
American Journal of Medical Quality 2000;15:16-25.
ABSTRACT  

Reviews: Fluvastatin: Effects Beyond Cholesterol Lowering
Corsini
J CARDIOVASC PHARMACOL THER 2000;5:161-175.
ABSTRACT  

The Emerging Epidemic of Atherosclerosis: Call for Papers
Winker
JAMA 1999;281:84-85.
FULL TEXT